These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 36537267

  • 1. Design, synthesis, biological evaluation and molecular docking of cyclic biguanidine compounds as cholinesterase inhibitors.
    Gungor O, Kose M.
    J Biomol Struct Dyn; 2023 Dec; 41(20):10885-10899. PubMed ID: 36537267
    [Abstract] [Full Text] [Related]

  • 2. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
    Riazimontazer E, Sadeghpour H, Nadri H, Sakhteman A, Tüylü Küçükkılınç T, Miri R, Edraki N.
    Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
    Pang X, Fu H, Yang S, Wang L, Liu AL, Wu S, Du GH.
    Molecules; 2017 Jul 26; 22(8):. PubMed ID: 28933746
    [Abstract] [Full Text] [Related]

  • 5. A Series of Novel 1-H-isoindole-1,3(2H)-dione Derivatives as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: In Silico, Synthesis and In Vitro Studies.
    Krzyżak E, Marciniak A, Szkatuła D, Jankowska KA, Dobies N, Kotynia A.
    Molecules; 2024 Jul 26; 29(15):. PubMed ID: 39124935
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
    Parlar S, Bayraktar G, Tarikogullari AH, Alptüzün V, Erciyas E.
    Chem Pharm Bull (Tokyo); 2016 Jul 26; 64(9):1281-7. PubMed ID: 27581632
    [Abstract] [Full Text] [Related]

  • 7. Design, Synthesis, In Vitro Biological Evaluation and In Silico Molecular Docking Study of Benzimidazole-Based Oxazole Analogues: A Promising Acetylcholinesterase and Butyrylcholinesterase Inhibitors.
    Hussain R, Rahim F, Ullah H, Khan S, Sarfraz M, Iqbal R, Suleman F, Al-Sadoon MK.
    Molecules; 2023 Oct 10; 28(20):. PubMed ID: 37894494
    [Abstract] [Full Text] [Related]

  • 8. Multipotent Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease: Synthesis, Biological Analysis and Molecular Docking Study of Benzimidazole-Based Thiazole Derivatives.
    Hussain R, Ullah H, Rahim F, Sarfraz M, Taha M, Iqbal R, Rehman W, Khan S, Shah SAA, Hyder S, Alhomrani M, Alamri AS, Abdulaziz O, Abdelaziz MA.
    Molecules; 2022 Sep 18; 27(18):. PubMed ID: 36144820
    [Abstract] [Full Text] [Related]

  • 9. A multifunctional anti-AD approach: Design, synthesis, X-ray crystal structure, biological evaluation and molecular docking of chrysin derivatives.
    Yang A, Liu C, Zhang H, Wu J, Shen R, Kou X.
    Eur J Med Chem; 2022 Apr 05; 233():114216. PubMed ID: 35227980
    [Abstract] [Full Text] [Related]

  • 10. Synthesis, characterisation, DNA binding, acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) activities and molecular docking studies of metal(II) complexes with 1,10-phenanthroline scaffold.
    Gladis EHE, Nagashri K, Anisha M, Joseph J.
    J Biomol Struct Dyn; 2023 Jul 05; 41(11):5067-5085. PubMed ID: 35699274
    [Abstract] [Full Text] [Related]

  • 11. Synthesis of New Triazole-Based Thiosemicarbazone Derivatives as Anti-Alzheimer's Disease Candidates: Evidence-Based In Vitro Study.
    Rahim F, Ullah H, Taha M, Hussain R, Sarfraz M, Iqbal R, Iqbal N, Khan S, Ali Shah SA, Albalawi MA, Abdelaziz MA, Alatawi FS, Alasmari A, Sakran MI, Zidan N, Jafri I, Khan KM.
    Molecules; 2022 Dec 20; 28(1):. PubMed ID: 36615218
    [Abstract] [Full Text] [Related]

  • 12. Bioactivity of hamamelitannin, flavokawain A, and triacetyl resveratrol as natural compounds: Molecular docking study, anticolon cancer, and anti-Alzheimer potentials.
    Zhang M, Xue J, Chen X, Elsaid FG, Salem ET, Ghanem RA, El-Kott AF, Xu Z.
    Biotechnol Appl Biochem; 2023 Apr 20; 70(2):730-745. PubMed ID: 35933706
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, biological evaluation and molecular modeling studies of methyl indole-isoxazole carbohydrazide derivatives as multi-target anti-Alzheimer's agents.
    Iraji A, Nikfar P, Nazari Montazer M, Karimi M, Edraki N, Saeedi M, Mirfazli SS.
    Sci Rep; 2024 Sep 10; 14(1):21115. PubMed ID: 39256495
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.
    Shamsimeymandi R, Pourshojaei Y, Eskandari K, Mohammadi-Khanaposhtani M, Abiri A, Khodadadi A, Langarizadeh A, Sharififar F, Amirheidari B, Akbarzadeh T, Lotfian H, Foroumadi A, Asadipour A.
    Arch Pharm (Weinheim); 2019 Jul 10; 352(7):e1800352. PubMed ID: 31136018
    [Abstract] [Full Text] [Related]

  • 15. Design, synthesis and biological evaluation of bakuchiol derivatives as multi-target agents for the treatment of Alzheimer's disease.
    Zhang XQ, Xiang YN, Qin T, Zou JP, Guo QW, Han ST, Zhang ZY, Liu WW, Ding G, Dong JQ, Shi DH.
    Fitoterapia; 2024 Apr 10; 174():105867. PubMed ID: 38382891
    [Abstract] [Full Text] [Related]

  • 16. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
    Manzoor S, Prajapati SK, Majumdar S, Raza MK, Gabr MT, Kumar S, Pal K, Rashid H, Kumar S, Krishnamurthy S, Hoda N.
    Eur J Med Chem; 2021 Apr 05; 215():113224. PubMed ID: 33582578
    [Abstract] [Full Text] [Related]

  • 17. Synthesis of indole derivatives as Alzheimer inhibitors and their molecular docking study.
    Homoud ZA, Taha M, Rahim F, Iqbal N, Nawaz M, Farooq RK, Wadood A, Alomari M, Islam I, Algheribe S, Rehman AU, Khan KM, Uddin N.
    J Biomol Struct Dyn; 2023 Nov 05; 41(19):9865-9878. PubMed ID: 36404604
    [Abstract] [Full Text] [Related]

  • 18. New cholinesterase inhibitors for Alzheimer's disease: Structure activity relationship, kinetics and molecular docking studies of 1-butanoyl-3-arylthiourea derivatives.
    Larik FA, Shah MS, Saeed A, Shah HS, Channar PA, Bolte M, Iqbal J.
    Int J Biol Macromol; 2018 Sep 05; 116():144-150. PubMed ID: 29729344
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and molecular modelling of thiadizole based hydrazone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitory activities.
    Işık A, Acar Çevik U, Karayel A, Celik I, Erçetin T, Koçak A, Özkay Y, Kaplancıklı ZA.
    SAR QSAR Environ Res; 2022 Mar 05; 33(3):193-214. PubMed ID: 35243936
    [Abstract] [Full Text] [Related]

  • 20. The biguanide-sulfonamide derivatives: synthesis, characterization and investigation of anticholinesterase inhibitory, antioxidant and DNA/BSA binding properties.
    Gungor O, Kose M.
    J Biomol Struct Dyn; 2023 Mar 05; 41(24):14952-14967. PubMed ID: 36858484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.